MIRA INFORM REPORT

 

 

Report Date :

04.01.2014

 

IDENTIFICATION DETAILS

 

Name :

BEACONS PHARMACEUTICALS PTE. LTD.

 

 

Formerly Known As :

BEACONS CHEMICALS (PRIVATE) LIMITED

 

 

Registered Office :

21, Chin Bee Avenue, 619942

 

 

Country :

Singapore

 

 

Financials (as on) :

31.12.2012

 

 

Date of Incorporation :

06.10.1970

 

 

Com. Reg. No.:

197000900-D

 

 

Legal Form :

Private Limited

 

 

Line of Business :

Manufacturing Pharmaceutical Products

 

 

No. of Employees :

100 [2013]

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

 

 

Payment Behaviour :

No complaints

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2013

 

Country Name

Previous Rating

(30.06.2013)

Current Rating

(30.09.2013)

Singapore

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

SINGAPORE - ECONOMIC OVERVIEW

 

Singapore has a highly developed and successful free-market economy. It enjoys a remarkably open and corruption-free environment, stable prices, and a per capita GDP higher than that of most developed countries. The economy depends heavily on exports, particularly in consumer electronics, information technology products, pharmaceuticals, and on a growing financial services sector. Real GDP growth averaged 8.6% between 2004 and 2007. The economy contracted 0.8% in 2009 as a result of the global financial crisis, but rebounded 14.8% in 2010, on the strength of renewed exports, before slowing to 5.2% in 2011 and 1.3% in 2012, largely a result of soft demand for exports during the second European recession. Over the longer term, the government hopes to establish a new growth path that focuses on raising productivity, which has sunk to an average of about 1.0% in the last decade. Singapore has attracted major investments in pharmaceuticals and medical technology production and will continue efforts to establish Singapore as Southeast Asia's financial and high-tech hub.

 

Source : CIA

 


 

EXECUTIVE SUMMARY

 

 

REGISTRATION NO.

:

197000900-D

COMPANY NAME

:

BEACONS PHARMACEUTICALS PTE. LTD.

FORMER NAME

:

BEACONS CHEMICALS (PRIVATE) LIMITED (26/09/2002)

INCORPORATION DATE

:

06/10/1970

COMPANY STATUS

:

EXIST

LEGAL FORM

:

PRIVATE LIMITED

LISTED STATUS

:

NO

REGISTERED ADDRESS

:

21, CHIN BEE AVENUE, 619942, SINGAPORE.

BUSINESS ADDRESS

:

2, SECOND CHIN BEE ROAD, 618769, SINGAPORE.

TEL.NO.

:

65-62652336

FAX.NO.

:

65-62615723

WEB SITE

:

WWW.BEACONS.COM.SG

CONTACT PERSON

:

LAM WEI CHAK ( MANAGING DIRECTOR )

PRINCIPAL ACTIVITY

:

MANUFACTURING PHARMACEUTICAL PRODUCTS

ISSUED AND PAID UP CAPITAL

:

600,003.00 ORDINARY SHARE, OF A VALUE OF SGD 600,003.00
250,000.00 PREFERENCE SHARE, OF A VALUE OF SGD 250,000.00

SALES

:

SGD 8,666,422 [2012]

NET WORTH

:

SGD 7,200,953 [2012]

STAFF STRENGTH

:

100 [2013]

LITIGATION

:

CLEAR

FINANCIAL CONDITION

:

LIMITED

PAYMENT

:

GOOD

MANAGEMENT CAPABILITY

:

AVERAGE

COMMERCIAL RISK

:

MODERATE

CURRENCY EXPOSURE

:

MODERATE

GENERAL REPUTATION

:

GOOD

INDUSTRY OUTLOOK

:

MATURE

 


HISTORY / BACKGROUND

 

The Subject is a private limited company and is allowed to have a minimum of one and a maximum of forty-nine shareholders. As a private limited company, the Subject must have at least two directors. A private limited company is a separate legal entity from its shareholders. As a separate legal entity, the Subject is capable of owning assets, entering into contracts, sue or be sued by other companies. The liabilities of the shareholders are to the extent of the equity they have taken up and the creditors cannot claim on shareholders' personal assets even if the Subject is insolvent. The Subject is governed by the Companies Act and the company must file its annual returns, together with its financial statements with the Registrar of Companies.

The Subject is principally engaged in the (as a / as an) manufacturing pharmaceutical products.

 

The immediate and ultimate holding company of the Subject is VALUED PARTNERS RESOURCES INC., a company incorporated in VIRGIN ISLANDS, BRITISH.

 

Share Capital History

Date

Issue & Paid Up Capital

31/12/2013

SGD 850,003.00

 

The major shareholder(s) of the Subject are shown as follows :


Name

Address

IC/PP/Loc No

Shareholding

(%)

VALUED PARTNERS RESOURCES INC.

WICKHAMS CAY 1, ROAD TOWN, TORTOLA, P.O.BOX 362, OMAR HODGE BUILDING, BV1, 3RD FLOOR, VIRGIN ISLANDS, BRITISH.

T07UF3259D

590,002.00

69.41

JOSEPH LAM WEI CHAK +

25, DUKE'S ROAD, 01-06, DUKES RESIDENCE, 268906, SINGAPORE.

S2200567G

250,000.00

29.41

IVANA KUT VOON POR +

25, DUKE'S ROAD, 01-06, DUKES RESIDENCE, 268906, SINGAPORE.

S7285122F

1.00

0.00

YOUNG PO WAH

9H, YUAN CHING ROAD, 06 - 84 LAKESIDE TOWER, 618650, SINGAPORE.

S2184418G

10,000.00

1.18

 

 

 

---------------

------

 

 

 

850,003.00

100.00

 

 

 

============

=====

+ Also Director

 

The Subject interest in other companies (Subsidiaries/Associates) are shown as follow :



Local No

Country

Company

(%)

As At

591612H

MALAYSIA

HEALTH LIFESPRING SDN. BHD.

100.00

31/12/2013

 

 

 

 

 

 


 

DIRECTORS

 

DIRECTOR 1

Name Of Subject

:

LAM MEI SIEM @ LEI MEISEN

Address

:

7, LINCOLN ROAD, 09-01, LINCH, THE, 308346, SINGAPORE.

IC / PP No

:

S7506187J

 

 

 

 

 

 

 

 

 

Nationality

:

SINGAPOREAN

Date of Appointment

:

18/09/2000

 

 

 

 

 

 

 

 

 

 

 

 

 

DIRECTOR 2

 

Name Of Subject

:

IVANA KUT VOON POR

Address

:

25, DUKE'S ROAD, 01-06, DUKES RESIDENCE, 268906, SINGAPORE.

IC / PP No

:

S7285122F

 

 

 

 

 

 

 

 

 

Nationality

:

SINGAPOREAN

Date of Appointment

:

03/03/2008

 

 

 

 

 

 

 

 

 

 

 

 

 

DIRECTOR 3

 

Name Of Subject

:

JOSEPH LAM WEI CHAK

Address

:

25, DUKE'S ROAD, 01-06, DUKES RESIDENCE, 268906, SINGAPORE.

IC / PP No

:

S2200567G

 

 

 

 

 

 

 

 

 

Nationality

:

SINGAPOREAN

Date of Appointment

:

16/01/2001

 

 

 

 

 

 

 

 

 

 

 

 



MANAGEMENT

 

 

 

1)

Name of Subject

:

LAM WEI CHAK

 

Position

:

MANAGING DIRECTOR

 

 

AUDITOR

 

Auditor

:

K.G. TAN & CO. PAC

Auditor' Address

:

111, NORTH BRIDGE ROAD #20- 02 PENINSULA PLAZA, 179098, SINGAPORE.

 

 

 

 

 

 

 

 

 

COMPANY SECRETARIES

 

1)

Company Secretary

:

HO SU-YEN CINDI

 

IC / PP No

:

S7701472A

 

 

 

 

 

Address

:

66, BEDOK SOUTH AVENUE 3, 21-508, 460066, SINGAPORE.

 

 

 

 

 

 

 

 

 

 

 

 

 

BANKING


No Banker found in our databank.

 

 

ENCUMBRANCE (S)


No encumbrance was found in our databank at the time of investigation.

 

 

LEGAL CHECK AGAINST SUBJECT


* A check has been conducted in our databank againt the Subject whether the subject has been involved in any litigation.

No legal action was found in our databank.


No winding up petition was found in our databank.

 

 

PAYMENT RECORD

 

 

 

SOURCES OF RAW MATERIALS:

Local

:

YES

Overseas

:

YES

 

 

 



The Subject refused to provide any name of trade/service supplier and we are unable to conduct any trade enquiry. However, from financial historical data we conclude that :

OVERALL PAYMENT HABIT

Prompt 0-30 Days

[

 

]

 

Good 31-60 Days

[

X

]

 

Average 61-90 Days

[

 

]

 

Fair 91-120 Days

[

 

]

 

Poor >120 Days

[

 

]

 

 

 

 

 

 



CLIENTELE

 

Local

:

YES

Percentage

:

100%

Domestic Markets

:

SINGAPORE

Overseas

:

NO

 

 

 

 

 

 

 

 

 

Credit Term

:

30 DAYS

 

 

 

 

 

 

Payment Mode

:

CASH
CHEQUES
TELEGRAPHIC TRANSFER (TT)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OPERATIONS

 

Products manufactured

:

PHARMACEUTICAL PRODUCTS

 

 

 

Brand Name

:

BEACONS

 

 

 

 

Total Number of Employees:

YEAR

2013

 

 

GROUP

N/A

 

 

 

 

 

 

 

 

COMPANY

100

 

 

 

 

 

 

 

 

 

Branch

:

NO

Other Information:


The Subject is principally engaged in the (as a / as an) manufacturing pharmaceutical products.

The Subject is Singapore’s largest manufacturer of generic pharmaceuticals, with a track record of success spanning of almost 40 years.


The Subject is one of the leading provider of high quality, fully integrated contract pharmaceutical manufacturing services, and also produces over 200 therapeutics in a variety of dosage forms



CURRENT INVESTIGATION

 

Latest fresh investigations carried out on the Subject indicated that :

Telephone Number Provided By Client

:

N/A

Current Telephone Number

:

65-62652336

Match

:

N/A

 

 

 

Address Provided by Client

:

NO. 2, SECOND CHIN BEE ROAD, SINGAPORE

Current Address

:

2, SECOND CHIN BEE ROAD, 618769, SINGAPORE.

Match

:

NO

 

 

 

 

Other Investigations


On 26th December 2013 we contacted one of the staff from the Subject and she provided some information on the Subject.


The address provided is incomplete.


The Subject refused to disclose its banker.



FINANCIAL ANALYSIS

 

 

Profitability

 

 

 

 

 

 

Turnover

:

Decreased

[

0.57%

]

 

Profit/(Loss) Before Tax

:

Decreased

[

<98.28%>

]

 

Return on Shareholder Funds

:

Unfavourable

[

<1.31%>

]

 

Return on Net Assets

:

Unfavourable

[

0.16%

]

 

 

 

 

 

 

 

 

The lower turnover could be due to the unfavourable market conditions.The Subject could be more efficient in controlling its operating costs and had managed to reduce its losses during the year. The Subject's unfavourable returns on shareholders' funds indicate the management's inefficiency in utilising its assets to generate returns.

 

 

 

 

 

 

 

Working Capital Control

 

 

 

 

 

 

Stock Ratio

:

Unfavourable

[

71 Days

]

 

Debtor Ratio

:

Favourable

[

47 Days

]

 

Creditors Ratio

:

Favourable

[

31 Days

]

 

 

 

 

 

 

 

 

The Subject could be incurring higher holding cost. As its capital was tied up in stocks, it could face liquidity problems. The favourable debtors' days could be due to the good credit control measures implemented by the Subject. The Subject had a favourable creditors' ratio where the Subject could be taking advantage of the cash discounts and also wanting to maintain goodwill with its creditors.

 

 

 

 

 

 

 

Liquidity

 

 

 

 

 

 

Liquid Ratio

:

Acceptable

[

0.98 Times

]

 

Current Ratio

:

Unfavourable

[

1.49 Times

]

 

 

 

 

 

 

 

 

The Subject's liquid ratio was slightly low. This could indicate that the Subject's working capital was slightly deficient. The Subject will have to improve its liquidity position either by obtaining short term financing or increase its paid up capital so that it can meet all its short term obligations as and when they fall due.

 

 

 

 

 

 

 

Solvency

 

 

 

 

 

 

Interest Cover

:

Unfavourable

[

0.61 Times

]

 

Gearing Ratio

:

Favourable

[

0.08 Times

]

 

 

 

 

 

 

 

 

The Subject's interest cover was low. If its profits fall or when interest rate rises, it  may not be able to meet all its interest payment. The Subject was lowly geared thus it had a low financial risk. The Subject was mainly financed by its shareholders' funds and internally generated funds. In times of economic slowdown / downturn, the Subject being a lowly geared company, will be able to compete better than those companies which are highly geared in the same industry.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Overall Assessment :

 

 

 

 

 

 

Although the Subject's turnover decreased, its losses also decreased during the year. This could be the result of more efficient control in its operating costs. The Subject's liquidity was at an acceptable range. If the Subject is able to obtain further short term financing, it should be able to meet all its short term obligations. If there is a fall in the Subject's profit or any increase in interest rate, the Subject may not be able to generate sufficient cash-flow to service its interest. The Subject as a lowly geared company, will be more secured compared to those highly geared companies. It has the ability to meet all its long term obligations.

 

 

 

 

 

 

 

Overall financial condition of the Subject : LIMITED

 

SINGAPORE ECONOMIC / INDUSTRY OUTLOOK

 

 

Major Economic Indicators :

2008

2009

2010

2011

2012

 

 

 

 

 

 

Population (Million)

4.84

4.98

5.08

5.18

5.31

Gross Domestic Products ( % )

1.5

<0.8>

14.5

4.9

1.3

Consumer Price Index

6.6

0.6

2.8

5.2

4.6

Total Imports (Million)

450,892.6

356,299.3

423,221.8

459,655.1

474,554.0

Total Exports (Million)

476,762.2

391,118.1

478,840.7

514,741.2

510,329.0

 

 

 

 

 

 

Unemployment Rate (%)

2.2

3.2

2.2

2.1

2.0

Tourist Arrival (Million)

10.12

9.68

11.64

13.17

14.37

Hotel Occupancy Rate (%)

81.0

75.8

85.6

86.5

86.4

Cellular Phone Subscriber (Million)

1.31

1.37

1.43

1.50

1.52

 

 

 

 

 

 

Registration of New Companies (No.)

25,327

26,414

29,798

32,317

31,892

Registration of New Companies (%)

<2.2>

4.3

12.8

8.5

<1.3>

Liquidation of Companies (No.)

10,493

22,393

15,126

19,005

17,218

Liquidation of Companies (%)

13.7

113.4

<32.5>

25.6

9.4

 

 

 

 

 

 

Registration of New Businesses (No.)

24,850

26,876

23,978

23,494

24,788

Registration of New Businesses (%)

0.36

8.15

<10.78>

2.02

5.51

Liquidation of Businesses (No.)

21,150

23,552

24,211

23,005

22,489

Liquidation of Businesses (%)

<0.8>

11.4

2.8

<5>

<2.2>

 

 

 

 

 

 

Bankruptcy Orders (No.)

2,326

2,058

1,537

1,527

1,748

Bankruptcy Orders (%)

<15.9>

<11.5>

<25.3>

<0.7>

14.5

Bankruptcy Discharges (No.)

1,500

3,056

2,252

1,391

1,881

Bankruptcy Discharges (%)

<7.7>

103.7

<26.3>

<38.2>

35.2

 

 

 

 

 

 

INDUSTRIES ( % of Growth ) :

 

 

 

 

 

Agriculture

 

 

 

 

 

Production of Principal Crops

<0.32>

3.25

<0.48>

4.25

3.64

Fish Supply & Wholesale

<6.31>

<1.93>

<10.5>

12.10

<0.5>

 

 

 

 

 

 

Manufacturing *

74.6

71.5

92.8

100.0

100.3

Food, Beverages & Tobacco

94.8

90.4

96.4

100.0

103.5

Textiles

180.1

145.9

122.1

100.0

104.0

Wearing Apparel

334.6

211.0

123.3

100.0

92.1

Leather Products & Footwear

128.2

79.5

81.8

100.0

98.6

Wood & Wood Products

132.0

101.4

104.0

100.0

95.5

Paper & Paper Products

101.0

95.4

106.1

100.0

97.4

Printing & Media

118.2

100.9

103.5

100.0

93.0

Crude Oil Refineries

113.1

96.4

95.6

100.0

99.4

Chemical & Chemical Products

84.5

80.3

97.6

100.0

100.5

Pharmaceutical Products

43.7

49.1

75.3

100.0

109.7

Rubber & Plastic Products

120.1

101.2

112.3

100.0

96.5

Non-metallic Mineral

96.5

91.9

92.5

100.0

98.2

Basic Metals

109.8

92.6

102.2

100.0

90.6

Fabricated Metal Products

101.3

90.8

103.6

100.0

104.3

Machinery & Equipment

65.0

57.3

78.5

100.0

112.9

Electrical Machinery

81.7

86.8

124.1

100.0

99.3

Electronic Components

93.1

85.2

113.6

100.0

90.6

Transport Equipment

102.0

96.0

94.0

100.0

106.3

 

 

 

 

 

 

Construction

45.90

<36.9>

14.20

20.50

28.70

Real Estate

<11.2>

1.4

21.3

25.4

31.9

 

 

 

 

 

 

Services

 

 

 

 

 

Electricity, Gas & Water

<1.3>

1.70

4.00

7.00

6.30

Transport, Storage & Communication

11.60

3.90

12.80

7.40

5.30

Finance & Insurance

<5.9>

<16.4>

<0.4>

8.90

0.50

Government Services

17.40

4.50

9.70

6.90

6.00

Education Services

0.50

0.10

<0.9>

<1.4>

0.30

 

 

 

 

 

 

* Based on Index of Industrial Production (2011 = 100)

 

 

 

 

 



INDUSTRY ANALYSIS

 

INDUSTRY :

MANUFACTURING

 

 

 

The manufacturing sector contracted by 1.1% in the fourth quarter of 2012, led by declines in the electronics and precision engineering clusters. These clusters were weighed down by weak global demand for semiconductors and semiconductor-related equipment. For the whole year of 2012, the manufacturing sector grew by 0.1%, significantly lower than the 7.8% recorded in 2011 when the sector was boosted by a surge in the growth of the biomedical manufacturing cluster.

 

Output of the biomedical manufacturing cluster grew by 2.4% in the fourth quarter. The expansion was driven by the medical technology segment which grew by a healthy 9.2%, benefitting from robust export demand for medical devices. The pharmaceuticals segment also grew by a modest 1.1%. For 2012, the biomedical manufacturing cluster expanded by 9.9%.

 

Output of the transport engineering cluster expanded by 4.9% in the fourth quarter. The aerospace segment grew by 6.2%, supported by higher demand for repair jobs from commercial airlines. Similarly, the marine & offshore engineering segment expanded by 5.0%, on the back of higher contributions from oil rig projects and oilfield equipment components. In the year 2012, the transport engineering cluster surged by 11%.

 

The output of the precision engineering cluster shrank by 1.3% in the fourth quarter. The decline was led by the 5.3% contraction in the machinery & systems segment, which saw weak export demand for semiconductor-related equipment. On the other hand, the precision modules & components segment grew by 2.9%, supported by higher production of optical instruments & photographic equipment and electronic connectors. In 2012, the precision engineering cluster expanded by 1.3%.

 

The general manufacturing cluster's output grew by 1.2% in the fourth quarter, driven by the 6.4% growth in the miscellaneous industries segment. The segment's growth was supported by higher production of batteries and constructionrelated materials. By contrast, the printing and food, beverages & tobacco segments declined by 6.4% and 1.3% respectively. For 2012, the general manufacturing cluster grew by 2.0%.

 

The chemicals cluster's output grew by 7.7% in the fourth quarter. The petrochemicals and petroleum segments registered growth of 9.3% and 6.3% respectively, partly due to the low base from plant shutdowns in end of 2011. The specialty chemicals segment also expanded by 8.0% on the back of higher regional demand. For the year 2012, the chemicals cluster declined by 0.4%, primarily due to weak regional demand for specialty chemicals in the second and third quarter of 2012.

 

Output of the electronics cluster contracted by 10% in the fourth quarter, led by the semiconductors and computer peripherals segments which contracted by 13% and 15% respectively. By contrast, the data storage segment grew by 7.8%, mainly due to the low base in end of 2011 when floods in Thailand had disrupted the supply chain for data storage products. For the whole of 2012, the electronics cluster contracted by 11%.

 

 

OVERALL INDUSTRY OUTLOOK : MATURE



CREDIT RISK EVALUATION & RECOMMENDATION

 

 

Incorporated in 1970, the Subject is a Private Limited company, focusing on manufacturing pharmaceutical products. The Subject has been in business for over 4 decades. It has built up a strong clientele base and good reputation will enable the Subject to further enhance its business in the near term. The Subject is expected to enjoy a stable market shares. Having strong support from its holding company has enabled the Subject to remain competitive despite the challenging business environment.


Over the years, the Subject should have build up its clientele base and received supports from its regular customers. Investigation revealed that the Subject's interest lies mostly in the local market. Thus, any adverse changes to the local economy might have a negative impact on the Subject's business performance. Being a moderate size company, the Subject has a total workforce of 100 employees in its business operations. Overall, we regard that the Subject's management capability is average. This indicates that the Subject has greater potential to improve its business performance and raising income for the Subject.


Due to the challenging market conditions, the Subject's business performance seems to be deteriorating and losses incurred. The Subject has generated an unfavourable return on shareholders' funds indicating that the management was inefficient in utilising its funds to generate return. The Subject however managed to maintain an adequate liquidity level, indicating that the Subject has the ability to meet its financial obligations. Being a lowly geared company, the Subject is exposed to low financial risk as it is mainly dependent on its internal funds to finance its business needs. Given a positive net worth standing at SGD 7,200,953, the Subject should be able to maintain its business in the near terms.

 
Having a strong assets backing, the Subject possesses latent assets as collateral for further financial extension. Hence, it has good chance of getting loans if the needs arises. The Subject's supplier are from both the local and overseas countries. This will eliminates the risk of dependency on deliveries from a number of key suppliers and insufficient quantities of its raw materials. Overall the Subject has a good control over its resources.

 
Overall, the Subject's payment habit is good as the Subject has a good credit control and it could be taking advantage of the cash discounts while maintaining a good reputation with its creditors.


The industry has reached its optimum level and is generally stable. It is saturated and very competitive. As the Subject is long presence in the market, it should have acquired competitive edge against other players in the same fields.


Based on the above condition, we recommend credit be granted to the Subject normally.

 



PROFIT AND LOSS ACCOUNT

 

 

THE FINANCIAL STATEMENTS WERE PREPARED IN ACCORDANCE WITH SINGAPORE FINANCIAL REPORTING STANDARDS.

 

Financial Year End

2012-12-31

2011-12-31

Months

12

12

Consolidated Account

GROUP

GROUP

Audited Account

YES

YES

Unqualified Auditor's Report (Clean Opinion)

YES

YES

Financial Type

FULL

FULL

Currency

SGD

SGD

Unit

 

 

 

 

 

TURNOVER

8,666,422

8,716,223

 

----------------

----------------

Total Turnover

8,666,422

8,716,223

Costs of Goods Sold

<5,850,500>

<6,334,037>

 

----------------

----------------

Gross Profit

2,815,922

2,382,186

 

----------------

----------------

 

 

 

PROFIT/(LOSS) FROM OPERATIONS

<7,995>

<465,435>

 

----------------

----------------

PROFIT/(LOSS) BEFORE TAXATION

<7,995>

<465,435>

Taxation

<86,000>

114,000

 

----------------

----------------

PROFIT/(LOSS) AFTER TAXATION

<93,995>

<351,435>

 

----------------

----------------

RETAINED PROFIT/(LOSS) BROUGHT FORWARD

 

 

As previously reported

6,285,382

6,681,817

 

----------------

----------------

As restated

6,285,382

6,681,817

 

----------------

----------------

PROFIT AVAILABLE FOR APPROPRIATIONS

6,191,387

6,330,382

DIVIDENDS - Ordinary (paid & proposed)

-

<45,000>

 

----------------

----------------

RETAINED PROFIT/(LOSS) CARRIED FORWARD

6,191,387

6,285,382

 

=============

=============

 

 

 

INTEREST EXPENSE (as per notes to P&L)

 

 

Lease interest

9,760

6,736

Term loan / Borrowing

10,784

18,272

 

20,544

25,008

 

 

 

BALANCE SHEET

 

 

 

ASSETS EMPLOYED:

 

 

FIXED ASSETS

6,064,134

6,733,169

 

 

 

 

----------------

----------------

TOTAL LONG TERM ASSETS

6,064,134

6,733,169

 

 

 

CURRENT ASSETS

 

 

Stocks

1,692,059

1,927,044

Trade debtors

1,106,381

1,105,002

Other debtors, deposits & prepayments

76,609

110,521

Short term deposits

75,476

75,212

Amount due from related companies

101,610

101,610

Cash & bank balances

1,650,474

1,322,397

Others

276,550

107,100

 

----------------

----------------

TOTAL CURRENT ASSETS

4,979,159

4,748,886

 

----------------

----------------

TOTAL ASSET

11,043,293

11,482,055

 

=============

=============

 

 

 

CURRENT LIABILITIES

 

 

Trade creditors

499,098

741,191

Other creditors & accruals

518,911

570,997

Hire purchase & lease creditors

58,386

48,657

Short term borrowings/Term loans

161,604

145,331

Amounts owing to director

2,111,669

2,288,291

Provision for taxation

1,593

1,593

 

----------------

----------------

TOTAL CURRENT LIABILITIES

3,351,261

3,796,060

 

----------------

----------------

NET CURRENT ASSETS/(LIABILITIES)

1,627,898

952,826

 

----------------

----------------

TOTAL NET ASSETS

7,692,032

7,685,995

 

=============

=============

 

 

 

SHARE CAPITAL

 

 

Ordinary share capital

850,003

850,003

 

----------------

----------------

TOTAL SHARE CAPITAL

850,003

850,003

 

 

 

RESERVES

 

 

Retained profit/(loss) carried forward

6,191,387

6,285,382

Others

159,563

87,862

 

----------------

----------------

TOTAL RESERVES

6,350,950

6,373,244

 

 

 

 

----------------

----------------

SHAREHOLDERS' FUNDS/EQUITY

7,200,953

7,223,247

 

 

 

LONG TERM LIABILITIES

 

 

Long term loans

247,465

421,072

Lease obligations

126,614

10,676

Deferred taxation

117,000

31,000

 

----------------

----------------

TOTAL LONG TERM LIABILITIES

491,079

462,748

 

----------------

----------------

 

7,692,032

7,685,995

 

=============

=============

 

 

 

FINANCIAL RATIO

 

 

 

 

 

 

TYPES OF FUNDS

 

 

Cash

1,725,950

1,397,609

Net Liquid Funds

1,725,950

1,397,609

Net Liquid Assets

<64,161>

<974,218>

Net Current Assets/(Liabilities)

1,627,898

952,826

Net Tangible Assets

7,692,032

7,685,995

Net Monetary Assets

<555,240>

<1,436,966>

BALANCE SHEET ITEMS

 

 

Total Borrowings

594,069

625,736

Total Liabilities

3,842,340

4,258,808

Total Assets

11,043,293

11,482,055

Net Assets

7,692,032

7,685,995

Net Assets Backing

7,200,953

7,223,247

Shareholders' Funds

7,200,953

7,223,247

Total Share Capital

850,003

850,003

Total Reserves

6,350,950

6,373,244

LIQUIDITY (Times)

 

 

Cash Ratio

0.52

0.37

Liquid Ratio

0.98

0.74

Current Ratio

1.49

1.25

WORKING CAPITAL CONTROL (Days)

 

 

Stock Ratio

71

81

Debtors Ratio

47

46

Creditors Ratio

31

43

SOLVENCY RATIOS (Times)

 

 

Gearing Ratio

0.08

0.09

Liabilities Ratio

0.53

0.59

Times Interest Earned Ratio

0.61

<17.61>

Assets Backing Ratio

9.05

9.04

PERFORMANCE RATIO (%)

 

 

Operating Profit Margin

<0.09>

<5.34>

Net Profit Margin

<1.08>

<4.03>

Return On Net Assets

0.16

<5.73>

Return On Capital Employed

0.16

<5.69>

Return On Shareholders' Funds/Equity

<1.31>

<4.87>

Dividend Pay Out Ratio (Times)

0.00

0.13

NOTES TO ACCOUNTS

 

 

Contingent Liabilities

0

0



FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.41

UK Pound

1

Rs.102.54

Euro

1

Rs.85.20

 

 

INFORMATION DETAILS

 

Report Prepared by :

NNA

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.